Physician profile
Dennis Min
NPI 1104808518
$126,783.47
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120K · 2020: $6,309 · 2021: $383.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36,015.14 | 2019 | |
| Allergan, INC. | $33,189.26 | 2019 | |
| Romark Laboratories, Lc | $19,606.13 | 2019-2020 | |
| Daiichi Sankyo INC. | $15,245.25 | 2019-2020 | |
| Abbvie INC. | $10,531.17 | 2019 | |
| Concordia Pharmaceuticals INC. | $7,979.64 | 2019 | |
| Parapro, LLC | $2,933.09 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $383.33 | 2021 | |
| Redhill Biopharma INC. | $213.57 | 2020 | |
| Pfizer INC. | $151.82 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $128.40 | 2019 | |
| Ironwood Pharmaceuticals, INC | $84.63 | 2019 | |
| Gilead Sciences, INC. | $80.96 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $44.71 | 2019-2020 | |
| Alfasigma USA, INC. | $31.04 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $29.78 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.61 | 2019 | |
| Medtronic USA, INC. | $25.13 | 2020 | |
| Nestle Healthcare Nutrition INC. | $22.10 | 2020 | |
| Intercept Pharmaceuticals, INC. | $21.24 | 2020 | |
| Evoke Pharma, INC. | $18.15 | 2020 | |
| Olympus America INC. | $13.52 | 2019 | |
| Qol Medical, LLC | $8.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Min listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.